Hung Chiung-Yu, Wozniak Karen L, Cole Garry T
Department of Biology and South Texas Center for Emerging Infectious Diseases, University of Texas at San Antonio, San Antonio, TX, 78249, USA.
Biology Department, University of Texas at San Antonio, One UTSA Circle, San Antonio, TX, 78249-0662, USA.
Methods Mol Biol. 2016;1403:551-66. doi: 10.1007/978-1-4939-3387-7_31.
The incidence of systemic fungal infections has increased throughout the world, spurring much interest in developing effective vaccines. Coccidioidomycosis, also known as San Joaquin Valley fever, is a potentially life-threatening respiratory mycosis. A vaccine against Coccidioides infection would contribute significantly to the well-being of the approx. 30 million residents in the Southwestern USA as well as the multitude of travelers who annually visit the endemic regions. We have applied a live, attenuated vaccine (∆T) to explore the nature of vaccine immunity in mice after intranasal challenge with a potentially lethal dose of Coccidioides spores. Coccidioides spores are airborne and highly infectious for mammalian hosts and classified as a biosafety level 3 agent. T cells are critical in the development of protective immunity against a variety of microorganisms as well as the development of autoimmune disease and allergic responses. Profiles of cytokines detected in lung homogenates of ∆T-vaccinated mice were indicative of a mixed Th1, Th2, and Th17 immune response. We have developed an intracellular cytokine staining and flow cytometric (ICS) technique to measure activated CD4(+) and CD8(+) T cells and IFN-γ-, IL-4-, IL-5-, and IL-17A-producing T cells in the lungs of mice that are challenged with a potentially lethal dose of Coccidioides spores. The numbers of pulmonary Th1 and Th17 cells during the first 2 weeks post-challenge showed a progressive increase in vaccinated mice and corresponded with reduction of fungal burden. In this protocol, we describe the methodology for culture and isolation of the live, attenuated ΔT spores of Coccidioides used to vaccinate mice, preparation of pulmonary cells, and staining protocol for cell surface markers and intracellular cytokines. This is the most reliable and robust procedure to measure frequencies and numbers of each selected T-cell subsets in lungs of vaccinated versus control mice and can be readily applied to evaluate T-cell response against other microbial infections.
全身性真菌感染的发病率在全球范围内呈上升趋势,这激发了人们对开发有效疫苗的浓厚兴趣。球孢子菌病,也称为圣华金河谷热,是一种潜在的危及生命的呼吸道真菌病。针对球孢子菌感染的疫苗将极大地促进美国西南部约3000万居民以及每年前往流行地区的众多旅行者的健康。我们应用了一种减毒活疫苗(∆T),以探讨用潜在致死剂量的球孢子菌孢子经鼻攻击后小鼠体内疫苗免疫的性质。球孢子菌孢子通过空气传播,对哺乳动物宿主具有高度传染性,被归类为生物安全3级病原体。T细胞在针对多种微生物的保护性免疫的发展以及自身免疫性疾病和过敏反应的发展中起着关键作用。在接种∆T疫苗的小鼠肺匀浆中检测到的细胞因子谱表明存在混合的Th1、Th2和Th17免疫反应。我们开发了一种细胞内细胞因子染色和流式细胞术(ICS)技术,用于测量经潜在致死剂量的球孢子菌孢子攻击的小鼠肺中活化的CD4(+)和CD8(+) T细胞以及产生IFN-γ、IL-4、IL-5和IL-17A的T细胞。攻击后前2周肺中Th1和Th17细胞的数量在接种疫苗的小鼠中呈逐渐增加趋势,并与真菌负荷的降低相对应。在本方案中,我们描述了用于给小鼠接种疫苗的球孢子菌减毒活∆T孢子的培养和分离方法、肺细胞的制备以及细胞表面标志物和细胞内细胞因子的染色方案。这是测量接种疫苗小鼠与对照小鼠肺中每个选定T细胞亚群的频率和数量的最可靠、最稳健的程序,并且可以很容易地应用于评估针对其他微生物感染的T细胞反应。